About this release
This release by Public Health Scotland (PHS) reports on the prescribing of long acting reversible methods of contraception (LARC) in primary care and sexual health settings in Scotland. This includes the contraceptive implant, intrauterine device (IUD) and intrauterine system (IUS).
In primary care and sexual health settings combined in 2022/23:
- The LARC prescribing rate increased from 50 to 51.3 per 1,000 women between 2021/22 and 2022/23. It remains slightly lower than it was before the Covid-19 pandemic, 54.3 in 2019/20.
- There is variation in LARC prescribing across Health Board areas. Differences in the ages of patients living within the board areas and/or patients living in one area but accessing services in another may contribute to this variation.
- The contraceptive implant remained the most common type of LARC prescribed with rates of 23.6 per 1,000 women compared to 21.6 and 6 for the IUS and IUD respectively.
- There is variation in LARC prescribing rates across age groups. However, it should be noted that in 16% of prescriptions we do not know the patient's age which may mean that variation by age is less or more than it appears to be.
This report focuses on very long acting methods of contraception; namely the contraceptive implant, IUD and IUS. Contraceptive injections are also reported on but are presented separately.
In typical use, the ‘long acting’ methods of contraception have a lower failure rate than alternative reversible methods such as the contraceptive pill or condoms. In August 2011, the Sexual Health and Blood Borne Virus Framework 2011-2015 was launched, followed in 2015 by the Sexual Health and Blood Borne Virus Framework 2015-2020 Update. In August 2021, Reset and Rebuild: A Recovery Plan for Sexual Health and Blood Borne Virus Services was published, detailing the impacts of the Covid-19 pandemic on sexual health and blood borne virus services in Scotland. Increasing the availability of LARC is also one of the aims of the Scottish Government's recent Women's Health Plan which seeks to drive forward change and improvement in women's health.
The next release of this publication will be September 2024.
If you have an enquiry relating to this publication, please contact Duncan McMaster at firstname.lastname@example.org.
If you have a media enquiry relating to this publication, please contact the Communications and Engagement team.
Requesting other formats and reporting issues
If you require publications or documents in other formats, please email email@example.com.
To report any issues with a publication, please email firstname.lastname@example.org.